Europe and Middle East & Africa Respiratory Panel Testing Market

1. Europe and Middle East & Africa Respiratory Panel Testing Market Outlook 2031 The Europe and Middle East & Africa respiratory panel testing market was valued over US$1.6 Bn in 2020 It is estimated to expand at a CAGR of 5.1% from 2021 to 2031 The Europe and Middle East & Africa respiratory panel testing market isexpected to surpass the value of US$3.1 Bn by the end of 2031 Report respiratory-panel-testing-market.html Overview: https://www.transparencymarketresearch.com/emea- CE-marked Respiratory Panels Improving Patient Outcomes Rapid and automated detection of pathogens is significantly changing in the Europe and Middle East & Africa respiratory panel testing market. There is a demand for panels that test multiple viruses and bacteria that cause respiratory tract infections. Manufacturers are increasing the availability of panels that eliminate the need for precise measuring or pipetting. Fast turnaround time is preferred in respiratory panel testing. High sensitivity and specificity in respiratory panel testing is helping to boost product sales. Panels based on TGA (Therapeutic Goods Administration)-certified multiplex PCR (polymerase chain reaction) systems are boosting the credibility of healthcare brands. FDA-cleared and CE marked panels are helping to improve patient outcomes. FDA De Novo-authorized Panels Gain Demand for Diagnosis of COVID-19 Pathogens SARS-CoV-2 has become a top concern for patients and healthcare practitioners. Companies in the Europe and Middle East & Africa respiratory panel testing market are increasing the availability of products to reduce the stress of clinicians. However, several respiratory pathogens can cause nearly indistinguishable symptoms. Hence, companies are increasing R&D investment to develop FDA De Novo authorized panels that help clinicians to quickly diagnose respiratory infections, including COVID-19, RSV, influenza, and the likes. Manufacturers in the Europe and Middle East & Africa respiratory panel testing market are developing products that use a syndromic approach to accurately detect and identify the pathogens most commonly associated with respiratory infections. These panels are being used in combination with rapid respiratory PCR test results to enable better-informed diagnosis and treatment of patients. Request Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=84 240

2. Multiplex PCR-based Respiratory Viral Panels Provide Prompt Results PCR-based panels are increasingly replacing viral culture to detect pathogens. However, companies in the Europe and Middle East & Africa respiratory panel testing market should increase the availability of products to support pathogen detection, which is useful for clinicians and clinical microbiologists. PCR-based panels are emerging as an alternative to viral culture, since the latter is slow and labor-intensive. These panels are gaining popularity for the detection of viral nucleic acids and provide prompt results with high sensitivity & specificity. Manufacturers are boosting the production for multiplex PCR-based respiratory viral panels for the test of influenza, respiratory syncytial virus (RSV), and rhinovirus, among others. High Prevalence of Lower RTIs Fueling Demand for Respiratory Panel Testing The high prevalence of both self-limiting upper respiratory tract infections (RTIs) and more severe lower RTIs such as bronchitis & pneumonitis is fueling the demand for respiratory panel testing. It has been found that lower RTIs are a major cause for hospitalization, morbidity, and mortality in infants and the elderly. In order to reduce their treatment cost, respiratory panel testing is emerging as an effective strategy. Nasopharyngeal Swabs & Home Testing Fulfill Convenience Needs of Individuals Companies in the Europe and Middle East & Africa respiratory panel testing market are capitalizing on incremental opportunities, since PCR-based panels are a preferred option for the evaluation of severely immunocompromised patients with respiratory symptoms. The high prevalence of parainfluenza, human metapneumovirus (hMPV), and adenovirus is driving the demand for respiratory panel products. In order to tap revenue opportunities through eCommerce, manufacturers in the Europe and Middle East & Africa respiratory panel testing market are developing products that help to collect specimens through nasopharyngeal swab. The growing trend of home testing provided by labs is another driver contributing to market growth. The Europe and Middle East & Africa respiratory panel testing market is expanding due to product demand for testing human rhinovirus and human metapneumovirus, among others. Europe and Middle East & Africa Respiratory Panel Testing Market: Overview Respiratory panel testing is a diagnostic testing panel used for the detection of pathogens in the respiratory tract. The pathogen can be a virus, bacteria, and other organism, which affects the nose, throat, and lungs, and causes breathing issues.

3. Respiratory panel testing detects various viruses including adenovirus, flu, coronavirus, and other deadly viruses. The panel requires a single sample to run various tests for diagnosis of viruses and bacteria. Various testing panels offered by the key players are rapid and automatic for faster detection of the various viruses, such as SARS-CoV-2, in a short time. Europe and Middle East & Africa Respiratory Panel Testing Market: Key Drivers Rise in prevalence of hospital-acquired infections, increase in cases of coronavirus outbreak, and surge in asthma & COPD cases are projected to drive the respiratory panel testing market in EMEA. Availability of novel and cost-efficient respiratory disease testing devices, kits, software, and consumables will aid early diagnosis of these diseases. According to the European Centre for Disease Prevention and Control (ECDC) data, 3.1 million to 4.6 million patients acquire hospital-acquired infections every year. Launch of innovative COVID-19 kits & products and collaborations among key players are the other factors propelling the market in EMEA. In September 2020, DiaSorin received CE Mark for the addition of saliva specimens for use with the Simplexa COVID-19 Direct assay. In February 2020, altona Diagnostics GmbH launched the RealStar SARS-CoV-2 RT-PCR Kit 1.0. The assay is based on real-time RT-PCR technology for the detection of SARS- CoV-2 (previously 2019-nCoV), which is the causative agent of coronavirus disease 2019 (COVID-19). In July 2017, Anatolia Geneworks launched Bosphore Respiratory Pathogens Panel Kit v1. These strategic steps taken by key players are expected to augment the market during the forecast period. Market Segmentation: Europe and Middle East & Africa Respiratory Panel Testing Market In terms of specimen type, the respiratory panel testing market in EMEA has been bifurcated into viruses and bacteria. The viruses segment has been split into adenovirus, SARS-CoV-2, RSV, human metapneumo virus, rhinovirus/enterovirus, parainfluenza, virus flu A, coronavirus, flu B, HIN1 2009, and others. Majority of countries struggling with viral infections are in Central and Eastern Europe. The Czech Republic, a central European country with 10.7 million population, is the worst hit, where cases have risen sharply in the past few weeks. This factor is likely to boost the growth of the viruses segment during the forecast period. The bacteria segment has been segregated into mycoplasma pneumoniae, chlamydophila pneumonia, bordetella pertussis, bordetella parapertussis, and others. Based on panel type, the respiratory panel testing market in EMEA has been classified into syndromic full multiplex panel, and low plex panel. The syndromic full multiplex panel segment accounted for the largest market share in 2020, as syndromic full multiplex panel methods are usually used for the simultaneous detection of two or more target pathogenic DNA or RNA molecules by using several specific primers in a single PCR reaction. Furthermore, syndromic molecular testing has been integrated into routine clinical care, either to provide diagnostic, epidemiological, or patient

4. management information. These factors are anticipated to fuel the growth of the segment in the next few years. In terms of end-user, the respiratory panel testing market in EMEA has been divided into hospital point of-care testing, ref laboratories, hospitals, and others. Increase in incidence of respiratory diseases leads to rise in hospital admissions, which is expected to drive the segment during the forecast period. Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The respiratory panel testing market report provides current and expected revenue (US$ Mn) for each of these segments from 2021 to 2031, considering 2020 as the base year. The compound annual growth rate (percentage CAGR) has been provided for each segment and market from 2021 to 2031 along with market size estimations. Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&re p_id=84240 Regional Overview: Europe and Middle East & Africa Respiratory Panel Testing Market Europe dominated the Respiratory panel testing market in EMEA in 2020, accounting for 85.5% share. Rise in prevalence of respiratory diseases, increase in the geriatric population, and technological advancements in respiratory panel testing are projected to boost the growth of the market in the region during the forecast period. Moreover, increase in incidence of viral infections is anticipated to fuel the growth of the Respiratory panel testing market in Europe in the next few years. For instance, the U.K., Russia, France, Spain, and Italy reported the highest number of confirmed COVID-19 cases during the pandemic. Germany is expected to dominate the respiratory panel testing market in Europe in terms of market share during the forecast period. The country is considered to have robust and well-established medical diagnostics market. Outbreak of COVID-19 placed an enormous public health burden on the country, which is expected to drive the demand for testing panel in the market. In November 2021, the U.K. reported 9,637,190 confirmed coronavirus cases, which is likely to propel the respiratory panel testing market in the country. Major Players The respiratory panel testing market report concludes with the company profiles section, which includes key information about major players in the Respiratory panel testing market in EMEA Leading players analyzed in the report include oF. Hoffmann-La Roche Ltd. obioMerieux SA oMedline Industries, Inc.

5. oBecton oDickinson & Company oaltona Diagnostics GmbH oCerTest Biotec S.L. oAnatolia Geneworks oSeegene, Inc. oDiaSorin S.p.A. (Luminex) oQIAGEN oBiocartis About Transparency Market Research Transparency Market Research registered at Wilmington, Delaware, United States, is a global market research company providing custom research and consulting services. TMR provides in-depth insights into factors governing demand in the market. It divulges opportunities across various segments based on Source, Application, Sales Channel, and End-Use that will favor growth in the market over the next 9 years. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ Contact Rohit Bhisey Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com Blog: https://tmrblog.com Email:sales@transparencymarketresearch.com